Wei Xü

c ‐Met/DDR1 Dual‐Target Tyrosine Kinase Inhibitor Featuring an Imidazo[1,2‐A]pyridine Core

In this contribution, we report the design, synthesis, and bioactivity evaluation of a novel class of dual‐target tyrosine kinases inhibitors (TKIs). By linking imidazo[1,2‐a]pyridines with a commonly used cyclopropanecarboxylic acid pharmacophore fragment, a number of novel pote...